About
BIS provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.
- Name
- ProShares UltraShort Nasdaq Biotech
- Index tracked
- NASDAQ Biotechnology TR USD
- Type
- Other
- Expense ratio
- 3.2%
- Management fee
- 0.75%
- Dividend policy
- Quarterly
- NAV
- USD 11.1326 (08/20/2026)
- Issued units
- 165.52K (08/21/2026)
- Listing date
- Apr 6, 2010
- Sponsor
- ProShares
- Custodian
- JPMorgan Chase Bank, N.A.